\
&
Contact us
\
&
Contact us
This was 5 years ago
LocationWebinar
The start of Horizon Europe, the new EU Framework Programme for Research and Innovation, is approaching.
The Director-General of the Directorate “Research and Innovation” of the European Commission, Mr. Jean-Eric Paquet, will present all the novelties of the programme and answer your questions.
This will be followed by interviews with 2 beneficiaries of the Horizon 2020 programme.
And you will be also informed about the Belgian concertation groups, reponsible for preparing the position of the Belgian delegation in committees of the EU Framework Programme, and the NCP organisations in Belgium.
Participation is free but registration is mandatory, which will close on November 12 at 9 am.
Registration and full agenda can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
